| 創建日期 | 上市日期 | 董事長 | 總經理 |
|---|---|---|---|
| 90/11/12 | 102/11/12 | 韓開程 | 韓台賢 |
| EPS | 本益比 | 股價淨值比 | 現金殖利率 |
| 0.77(Q2) | 35.59 | 3.75 | 2.34% |
| 實收資本額 | 已發行普通股 | ||
| 672,722,630 | 67,272,263 | ||
| 主要經營業務 | |||
| 透明質酸(玻尿酸)醫療器材產品研發製造及銷售透明質酸(玻尿酸)保養品研發製造及銷售 | |||
| 公司網址 | |||
| scivision.com.tw | |||
科妍(1786) 月營收報表
| 年度/月份 | 營業收入（單位：千元） | 累計營業收入（單位：千元） | |||||
|---|---|---|---|---|---|---|---|
| 單月營收 | 去年同月營收 | 單月月增率 | 單月年增率 | 累計營收 | 去年累計營收 | 累積年增率 | |
| 2023/08 | 80,500 | 38,740 | 16.8% | 107.8% | 453,053 | 329,870 | 37.3% |
| 2023/07 | 68,910 | 58,552 | -3.2% | 17.7% | 372,553 | 291,130 | 28% |
| 2023/06 | 71,197 | 56,624 | 14.7% | 25.7% | 303,643 | 232,578 | 30.5% |
| 2023/05 | 62,058 | 43,648 | 24.1% | 42.2% | 232,446 | 175,954 | 32.1% |
| 2023/04 | 50,010 | 31,938 | -17.2% | 56.6% | 170,388 | 132,306 | 28.8% |
| 2023/03 | 60,387 | 56,981 | 148.8% | 6% | 120,378 | 100,368 | 19.9% |
| 2023/02 | 24,269 | 23,343 | -32.1% | 4% | 59,991 | 43,387 | 38.3% |
| 2023/01 | 35,722 | 20,044 | -44.7% | 78.2% | 35,722 | 20,044 | 78.2% |
| 2022/12 | 64,646 | 68,261 | 46.3% | -5.3% | 557,348 | 505,539 | 10.2% |
| 2022/11 | 44,174 | 37,816 | -13.5% | 16.8% | 492,702 | 437,278 | 12.7% |
| 2022/10 | 51,047 | 34,160 | -24.5% | 49.4% | 448,528 | 399,462 | 12.3% |
| 2022/09 | 67,611 | 41,094 | 74.5% | 64.5% | 397,481 | 365,302 | 8.8% |
| 2022/08 | 38,740 | 55,141 | -33.8% | -29.7% | 329,870 | 324,208 | 1.7% |
| 2022/07 | 58,552 | 31,034 | 3.4% | 88.7% | 291,130 | 269,067 | 8.2% |
| 2022/06 | 56,624 | 53,961 | 29.7% | 4.9% | 232,578 | 238,033 | -2.3% |
| 2022/05 | 43,648 | 42,418 | 36.7% | 2.9% | 175,954 | 184,072 | -4.4% |
| 2022/04 | 31,938 | 30,424 | -43.9% | 5% | 132,306 | 141,655 | -6.6% |
| 2022/03 | 56,981 | 57,676 | 144.1% | -1.2% | 100,368 | 111,231 | -9.8% |
| 2022/02 | 23,343 | 22,736 | 16.5% | 2.7% | 43,387 | 53,555 | -19% |
| 2022/01 | 20,044 | 30,819 | -70.6% | -35% | 20,044 | 30,819 | -35% |
| 2021/12 | 68,261 | 50,453 | 80.5% | 35.3% | 505,539 | 466,881 | 8.3% |
| 2021/11 | 37,816 | 30,491 | 10.7% | 24% | 437,278 | 416,427 | 5% |
| 2021/10 | 34,160 | 50,982 | -16.9% | -33% | 399,462 | 385,936 | 3.5% |
| 2021/09 | 41,094 | 23,850 | -25.5% | 72.3% | 365,302 | 334,954 | 9.1% |
| 2021/08 | 55,141 | 70,193 | 77.7% | -21.4% | 324,208 | 311,104 | 4.2% |
| 2021/07 | 31,034 | 26,917 | -42.5% | 15.3% | 269,067 | 240,910 | 11.7% |
| 2021/06 | 53,961 | 50,156 | 27.2% | 7.6% | 238,033 | 213,994 | 11.2% |
| 2021/05 | 42,418 | 25,455 | 39.4% | 66.6% | 184,072 | 163,838 | 12.4% |
| 2021/04 | 30,424 | 28,569 | -47.3% | 6.5% | 141,655 | 138,383 | 2.4% |
| 2021/03 | 57,676 | 49,756 | 153.7% | 15.9% | 111,231 | 109,814 | 1.3% |
| 2021/02 | 22,736 | 20,048 | -26.2% | 13.4% | 53,555 | 60,057 | -10.8% |
| 2021/01 | 30,819 | 40,009 | -38.9% | -23% | 30,819 | 40,009 | -23% |
| 2020/12 | 50,453 | 52,309 | 65.5% | -3.5% | 466,881 | 437,873 | 6.6% |
| 2020/11 | 30,491 | 39,009 | -40.2% | -21.8% | 416,427 | 385,564 | 8% |
| 2020/10 | 50,982 | 38,494 | 113.8% | 32.4% | 385,936 | 346,556 | 11.4% |
| 2020/09 | 23,850 | 31,461 | -66% | -24.2% | 334,954 | 308,062 | 8.7% |
科妍(1786) 歷年營收季增率
| 年度/季別 | 營收季增率 | 近4季營收季增率 | 年度/季別 | 營收季增率 | 近4季營收季增率 |
|---|---|---|---|---|---|
| 2023Q2 | 52.24% | 8.84% | 2020Q3 | 16.11% | 4.06% |
| 2023Q1 | -24.70% | 3.59% | 2020Q2 | -5.13% | 0.76% |
| 2022Q4 | -3.05% | 3.65% | 2020Q1 | -15.41% | 1.23% |
| 2022Q3 | 24.73% | 7.53% | 2019Q4 | 26.26% | 6.88% |
| 2022Q2 | 31.73% | 1.09% | 2019Q3 | 1.98% | 7.80% |
| 2022Q1 | -28.43% | -2.15% | 2019Q2 | -3.47% | 15.19% |
| 2021Q4 | 10.19% | 1.67% | 2019Q1 | 2.76% | -0.54% |
| 2021Q3 | 0.37% | 1.29% | 2018Q4 | 38.92% | 4.77% |
| 2021Q2 | 14.00% | 4.83% | 2018Q3 | 44.28% | 6.28% |
| 2021Q1 | -15.69% | 0.30% | 2018Q2 | -52.27% | -5.62% |
| 2020Q4 | 9.07% | 0.45% | 2018Q1 | 22.76% | 22.16% |
評論0